The impact of tumor hypoxia on the clinical efficacy of anti-PD-1 mAb treatment in recurrent/metastatic HNSCC patients (R/M).Dan P. Zandberg, Greg M. Delgoffe, Ashley V. Menk et al.|Journal of Clinical Oncology|2020Cited by 10